Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.580
+0.010 (0.64%)
Aug 8, 2025, 10:51 AM - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $171.08 million as of August 8, 2025. Its market cap has increased by 71.43% in one year.
Market Cap
171.08M
Enterprise Value
-18.04M
1-Year Change
71.43%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from $214.50M to $171.08M, a decrease of -20.24%. That is a compound annual growth rate of -2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 170.00M | -4.01% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
| Oct 7, 2015 | 214.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |